BioScience Health Innovations annual total assets
2020
2021
2022
2022
2023
2024
2025
BioScience Health Innovations Total Assets Growth & History (BHIC)
BioScience Health Innovations's total assets was $1.7M for fiscal 2025.
View full BioScience Health Innovations company overviewBioScience Health Innovations annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.7M | $833,393 | +95.38% |
| 2024 | 2024-12-31 | $873,788 | $780,400 | +835.65% |
| 2023 | 2023-12-31 | $93,388 | $61,780 | +195.46% |
| 2022 · Dec 31 | 2022-12-31 | $31,608 | — | — |
| 2022 · Aug 31 | 2022-08-31 | $16,253 | $9,939 | +157.41% |
| 2021 | 2021-08-31 | $6,314 | −$14,315 | −69.39% |
| 2020 | 2020-08-31 | $20,629 | — | — |
BioScience Health Innovations quarterly total assets
As of Aug 31, 2019
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q4.22
Q1.23
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.1M | $78,776 | +3.83% |
| Q1 2026 | 2026-03-31 | $2.3M | $935,280 | +67.05% |
| Q4 2025 | 2025-12-31 | $1.7M | $833,393 | +95.38% |
| Q3 2025 | 2025-09-30 | $2.1M | $1.7M | +397.10% |
| Q2 2025 | 2025-06-30 | $2.1M | $1.8M | +863.24% |
| Q1 2025 | 2025-03-31 | $1.4M | $1.2M | +801.15% |
| Q4 2024 | 2024-12-31 | $873,788 | $780,400 | +835.65% |
| Q3 2024 | 2024-09-30 | $415,830 | $320,829 | +337.71% |
| Q2 2024 | 2024-06-30 | $213,590 | $150,623 | +239.21% |
| Q1 2024 | 2024-03-31 | $154,798 | $127,422 | +465.45% |
| Q4 2023 | 2023-12-31 | $93,388 | $61,780 | +195.46% |
| Q3 2023 | 2023-09-30 | $95,001 | — | — |
| Q2 2023 | 2023-06-30 | $62,967 | — | — |
| Q1 2023 · Mar 31 | 2023-03-31 | $27,376 | — | — |
| Q1 2023 · Feb 28 | 2023-02-28 | $8,793 | −$62,314 | −87.63% |
| Q4 2022 · Dec 31 | 2022-12-31 | $31,608 | — | — |
| Q1 2023 · Nov 30 | 2022-11-30 | $28,343 | −$67,791 | −70.52% |
| Q4 2022 · Aug 31 | 2022-08-31 | $16,253 | $9,939 | +157.41% |
| Q3 2022 | 2022-05-31 | $24,456 | $24,082 | +6439.04% |
| Q2 2022 | 2022-02-28 | $71,107 | $68,724 | +2883.93% |
| Q1 2022 | 2021-11-30 | $96,134 | $76,083 | +379.45% |
| Q4 2021 | 2021-08-31 | $6,314 | −$14,315 | −69.39% |
| Q3 2021 | 2021-05-31 | $374 | −$22,500 | −98.36% |
| Q2 2021 | 2021-02-28 | $2,383 | −$5,556 | −69.98% |
| Q1 2021 | 2020-11-30 | $20,051 | $12,036 | +150.17% |
| Q4 2020 | 2020-08-31 | $20,629 | $18,729 | +985.74% |
| Q3 2020 | 2020-05-31 | $22,874 | — | — |
| Q2 2020 | 2020-02-29 | $7,939 | — | — |
| Q1 2020 | 2019-11-30 | $8,015 | — | — |
| As of Aug 31, 2019 | 2019-08-31 | $1,900 | — | — |
BioScience Health Innovations total assets trends
Between the periods ended 2020-08-31 and 2025-12-31, BioScience Health Innovations's total assets increased from $20,629 to $1.7M, a change of $1.7M. The latest reported quarter, Q2 2026, shows $2.1M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioScience Health Innovations source filings ↗